Signals

← Signals

☆BDRX

5 in-universe funds with a nonzero position in BDRX within the trailing 4 quarters, as of 2026Q2

Catalyst Timeline merged from Insider (Form 4), 8-K and Ownership/dilution filings already on file -- not a live news feed Full insider history

DateTypeWhat happened
2026-07-01 Ownership Dilution filing by Biodexa Pharmaceuticals Plc (424B5)
2024-08-01 Ownership Dilution filing by Biodexa Pharmaceuticals Plc (D)
2024-07-22 Ownership Dilution filing by Biodexa Pharmaceuticals Plc (424B5)
2024-01-04 Ownership Dilution filing by Biodexa Pharmaceuticals Plc (D)
2023-06-07 Ownership Dilution filing by Biodexa Pharmaceuticals Plc (D)
2023-05-26 Ownership Dilution filing by Biodexa Pharmaceuticals Plc (424B5)
2023-05-25 Ownership Dilution filing by Biodexa Pharmaceuticals Plc (424B5)
2023-02-17 Ownership Dilution filing by Biodexa Pharmaceuticals Plc (D)
2022-12-16 Ownership Dilution filing by Biodexa Pharmaceuticals Plc (424B5)
2020-06-04 Ownership Dilution filing by Biodexa Pharmaceuticals Plc (D)

Flow ranking

Rank#2971
Score / z0.000 / -0.02
Consensus1.83 over 4 funds
Momentumnot computed

Price & positioning

130 cached closes, trailing year
Drawdownnot computed
Short interestnot computed

Forensics

No XBRL fundamentals on file for this issuer — either not backfilled yet, or a financial/REIT excluded from these ratios. Not the same as clean.

Insider

No Form 4 activity on file for this ticker.

8-K events

Negative / total0 / 0

Ownership

13D / 13G / dilution0 / 0 / 1
FiledFormFiler
2026-07-01 424B5 Biodexa Pharmaceuticals Plc
2024-08-01 D Biodexa Pharmaceuticals Plc
2024-07-22 424B5 Biodexa Pharmaceuticals Plc
2024-01-04 D Biodexa Pharmaceuticals Plc
2023-06-07 D Biodexa Pharmaceuticals Plc
2023-05-26 424B5 Biodexa Pharmaceuticals Plc
2023-05-25 424B5 Biodexa Pharmaceuticals Plc
2023-02-17 D Biodexa Pharmaceuticals Plc
2022-12-16 424B5 Biodexa Pharmaceuticals Plc
2020-06-04 D Biodexa Pharmaceuticals Plc
Showing the 10 most recent.

LLM reads

Ticker Eval hasn't reached this ticker yet. It's gated to the top of the ranking, so this is an ordering artefact, not a judgement.
Quarter
Fund AUM ($M)
–
Fund Positions
–
Quarters Held
–

Fund holders

Fund ▾ Quality Q ▾ Positions ▾ Value ($M) ▾ % of Fund AUM ▾ Qtrs Held ▾ Δ 1Q ▾ Δ 2Q ▾ Δ 3Q ▾ Δ 4Q ▾
☆ARMISTICE CAPITAL, LLC CIK 0001601086 0.313 323 0.0 0.0% 1 +0.0 pp +0.0 pp +0.0 pp +0.0 pp
☆GAMMA Investing LLC CIK 0002010235 0.492 4173 0.0 0.0% 1 +0.0 pp +0.0 pp +0.0 pp +0.0 pp
☆SBI Securities Co., Ltd. CIK 0001851815 0.645 4072 0.0 0.0% 2 -0.0 pp +0.0 pp +0.0 pp +0.0 pp
☆UBS Group AG (UBS) CIK 0001610520 0.954 9044 0.0 0.0% 1 +0.0 pp +0.0 pp +0.0 pp +0.0 pp
☆Hilton Head Capital Partners, LLC CIK 0002109913 0.082 912 0.0 0.0% 1 +0.0 pp +0.0 pp +0.0 pp +0.0 pp
Value and % of AUM are this fund's own disclosed long-equity book (13F does not report true firm AUM). Positions is the fund's total position count (all tickers, not just BDRX). Qtrs Held counts distinct quarters this fund has actually held BDRX (weight > 0), across every period we've rescored. Fund AUM and Positions filters apply to the fund's whole book, not its BDRX position size. Δ columns are the percentage-point change in BDRX's weight within each fund's book vs. the trailing 1/2/3/4 quarters (2026Q1 / 2025Q4 / 2025Q3 / 2025Q2) — a fund not yet holding it that far back is treated as 0%. Only in-universe (quality-scored) funds are shown, matching the Signals-tab methodology.
Long US-equity 13F disclosures only · up to 45-day reporting lag · sells = reduce/avoid, not short. JSON: /api/signals · /api/funds · /api/status